SCHEMBL8937571

SCHEMBL8937571

CCCOc1ccc(C(=CC(=O)O)c2cccc(Cl)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.60
TP53 P04637 2/20 0.60
ALDH1A1 P00352 2/20 0.53
KMT2A Q03164 2/20 0.49
RXRA P19793 1/20 0.45
RXRB P28702 1/20 0.45
RXRG P48443 1/20 0.45
PLA2G4A P47712 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
LMNA P02545 2/20 0.44
MAPK1 P28482 1/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
PLK1 P53350 1/20 0.44
FAAH O00519 1/20 0.43
NR1H4 Q96RI1 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
NPC1 O15118 1/20 0.43
NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8937615 1.00 MAPT (0.60) MAPTTP53ALDH1A1KMT2ARXRA
SCHEMBL8937565 1.00 MAPT (0.60) MAPTTP53ALDH1A1KMT2ARXRA
SCHEMBL8937434 0.91 KMT2A (0.60) MAPTTP53ALDH1A1KMT2ALMNA
SCHEMBL8937306 0.91 KMT2A (0.60) MAPTTP53ALDH1A1KMT2ALMNA
SCHEMBL8937303 0.91 KMT2A (0.60) MAPTTP53ALDH1A1KMT2ALMNA
SCHEMBL8937346 0.87 NPC1 (0.54) MAPTTP53ALDH1A1KMT2AL3MBTL1
SCHEMBL8937347 0.87 NPC1 (0.54) MAPTTP53ALDH1A1KMT2AL3MBTL1
SCHEMBL8937343 0.87 NPC1 (0.54) MAPTTP53ALDH1A1KMT2AL3MBTL1
SCHEMBL8937229 0.85 L3MBTL1 (0.46) MAPTTP53ALDH1A1KMT2AL3MBTL1
SCHEMBL8937235 0.85 L3MBTL1 (0.46) MAPTTP53ALDH1A1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5559109-A Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist SANKKO COMPANY, LIMITED (JP) 1996-09-24 US disclosed
US-5556852-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
US-5369106-A N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists SANKYO COMPANY, LIMITED (JP) 1994-11-29 US disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed